THURSDAY, Sept. 19, 2024 (HealthDay News) — One of the most common diabetes drugs, metformin, might deliver an added bonus: Lowering users’ odds for Long COVID. Long COVID can present with symptoms including chronic fatigue, brain fog and chest pain and it may last weeks or months after an initial COVIDContinue Reading
THURSDAY, Sept. 19, 2024 (HealthDay News) — A specific class of diabetes drug appears to lower people’s risk for dementia and Parkinson’s disease, a new study shows. Sodium-glucose cotransporter-2 (SGLT2) inhibitors, also known as gliflozins, lower blood sugar by prompting the kidneys to filter sugar out of the bloodstream andContinue Reading
TUESDAY, Sept. 17, 2024 (HealthDay News) — A few cups of coffee each morning can help protect a person against heart disease, stroke and type 2 diabetes, a new study says. Drinking three cups of coffee a day — or about 200 to 300 milligrams of caffeine — lowered theContinue Reading
MONDAY, Sept. 16, 2024 (HealthDay News) — Fatty liver disease linked to diabetes and obesity can easily progress to liver cirrhosis, but new research suggests that GLP-1 medicines like Ozempic can help stop that. In a new decades-long study, veterans with diabetes and what’s known as metabolic dysfunction-associated steatotic liverContinue Reading
FRIDAY, Sept. 13, 2024 (HealthDay News) — Initially approved to treat type 2 diabetes, Ozempic and Mounjaro also can help people with type 1 diabetes lose weight and control their blood sugar levels, a new study finds. Overweight or obese type 1 diabetics taking Mounjaro were able to reduce theContinue Reading
FRIDAY, Sept. 13, 2024 (HealthDay News) — Fear of a having a low blood sugar crash dissuades many people with type 1 diabetes from getting the exercise they need, a new study finds. However, people were more likely to engage in exercise if their doctor discussed how to manage theirContinue Reading
WEDNESDAY, Sept. 11, 2024 (HealthDay News) — Weekly insulin shots can help control both type 1 and type 2 diabetes as well as daily injections do, a pair of clinical trials have found. A new class of insulin called efsitora alfa has been designed to require injections only once aContinue Reading
WEDNESDAY, Sept. 11, 2024 (HealthDay News) — People with diabetes are more prone to gum disease, due to the damage the chronic illness does to small blood vessels, a new study warns. Diabetics who suffer from other diseases caused by small blood vessel damage — diabetic retinopathy and neuropathy — areContinue Reading
TUESDAY, Sept. 10, 2024 (HealthDay News) — Taking steroids more than doubles a person’s risk of developing type 2 diabetes, a new study warns. Patients taking steroid pills, injections or infusions are 2.6 times more likely to develop diabetes than those not on steroids, researchers reported Sunday in a presentationContinue Reading
TUESDAY, Sept. 10, 2024 (HealthDay News) — People with type 2 diabetes are nearly twice as likely to develop asthma, a new review has concluded. Type 2 diabetics are 83% more likely to develop asthma, compared to those without diabetes, researchers found. The relationship also works the other way aroundContinue Reading